Health care companies in the United States by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Hims & Hers Health leads the 140 health care companies in the United States ranked by short interest, at 22.0%, ahead of Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 140
- First
- Hims & Hers Health22.0%
- Median
- 5.35%
- Combined market value
- SAR 27.39T
- Countries
- 1
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Hims & Hers HealthHIMS · Health Care | 22.0% | SAR 12.8B | SAR 54.77 | 8.86% down | 54% down | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | 19.2% | SAR 22B | SAR 180.56 | 4.45% down | 25% up | ||
| 3 | TG TherapeuticsTGTX · Health Care | 19.0% | SAR 35.9B | SAR 237.62 | 2.37% down | 103% up | ||
| 4 | GRAILGRAL · Health Care | 17.8% | SAR 16.7B | SAR 372.34 | 5.33% down | 12% up | ||
| 5 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SAR 29.2B | SAR 421.52 | 3.80% down | 15% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SAR 17.9B | SAR 317.19 | 0.33% down | 105% up | ||
| 7 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SAR 29.7B | SAR 455.43 | 2.11% down | 45% up | ||
| 8 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SAR 31.5B | SAR 1,127.06 | 3.37% down | 83% up | ||
| 9 | Twist BioscienceTWST · Health Care | 14.4% | SAR 26.4B | SAR 387.60 | 7.44% down | 291% up | ||
| 10 | CytokineticsCYTK · Health Care | 12.9% | SAR 26.5B | SAR 190.50 | 1.32% down | 21% down | ||
| 11 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SAR 16.6B | SAR 99.71 | 2.35% down | 64% down | ||
| 12 | Kodiak SciencesKOD · Health Care | 12.4% | SAR 23.8B | SAR 364.53 | 0.75% down | 371% up | ||
| 13 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SAR 21.5B | SAR 1,076.12 | 0.03% down | 44% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SAR 33.3B | SAR 350.65 | 4.26% down | 302% up | ||
| 15 | Halozyme TherapeuticsHALO · Health Care | 12.0% | SAR 39.1B | SAR 342.70 | 1.82% down | 32% up | ||
| 16 | ImmunityBioIBRX · Health Care | 11.9% | SAR 24B | SAR 22.58 | 8.37% down | 216% up | ||
| 17 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SAR 16.4B | SAR 149.70 | 3.07% down | 82% up | ||
| 18 | RadNetRDNT · Health Care | 11.3% | SAR 20.6B | SAR 261.52 | 0.29% up | 16% down | ||
| 19 | RepligenRGEN · Health Care | 11.0% | SAR 39.3B | SAR 614.53 | 3.81% down | 5% up | ||
| 20 | BridgeBio PharmaBBIO · Health Care | 10.7% | SAR 55.6B | SAR 285.23 | 2.75% down | 15% up | ||
| 21 | ErascaERAS · Health Care | 10.6% | SAR 17.9B | SAR 51.06 | 4.29% down | 387% up | ||
| 22 | ExelixisEXEL · Health Care | 10.5% | SAR 59.2B | SAR 242.46 | 1.82% down | 55% up | ||
| 23 | CG OncologyCGON · Health Care | 10.3% | SAR 26.6B | SAR 298.13 | 2.97% down | 93% up | ||
| 24 | Krystal BiotechKRYS · Health Care | 10.3% | SAR 34.3B | SAR 1,158.80 | 2.19% down | 49% up | ||
| 25 | TeleflexTFX · Health Care | 10.3% | SAR 24B | SAR 606.17 | 1.11% down | 48% up | ||
| 26 | Cogent BiosciencesCOGT · Health Care | 10.0% | SAR 17.4B | SAR 100.22 | 3.70% down | 25% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SAR 23.5B | SAR 360.63 | 0.65% up | 35% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | 9.96% | SAR 16.9B | SAR 176.32 | 2.69% down | 39% up | ||
| 29 | Kymera TherapeuticsKYMR · Health Care | 9.84% | SAR 36.9B | SAR 432.59 | 3.42% down | 81% up | ||
| 30 | VaxcytePCVX · Health Care | 9.70% | SAR 32.9B | SAR 207.80 | 5.09% down | 22% up | ||
| 31 | Oruka TherapeuticsORKA · Health Care | 9.53% | SAR 24.4B | SAR 359.43 | 1.80% down | 233% up | ||
| 32 | 10x GenomicsTXG · Health Care | 9.48% | SAR 25.6B | SAR 194.33 | 9.72% down | 213% up | ||
| 33 | PTC TherapeuticsPTCT · Health Care | 9.31% | SAR 17.7B | SAR 211.66 | 3.27% down | 26% down | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SAR 33B | SAR 1,422.19 | 4.45% down | 28% down | ||
| 35 | ImmunovantIMVT · Health Care | 8.96% | SAR 24.7B | SAR 119.19 | 2.31% down | 44% up | ||
| 36 | Henry ScheinHSIC · Health Care | 8.47% | SAR 34.6B | SAR 313.33 | 1.51% down | 16% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | 8.34% | SAR 26.1B | SAR 238.67 | 2.09% down | 16% down | ||
| 38 | ModernaMRNA · Health Care | 8.20% | SAR 296B | SAR 731.54 | 2.17% down | 740% up | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SAR 21.9B | SAR 155.20 | 5.22% down | 8% up | ||
| 40 | DaVitaDVA · Health Care | 8.17% | SAR 38B | SAR 604.10 | 3.00% up | 30% up | ||
| 41 | VeradermicsMANE · Health Care | 8.03% | SAR 18.9B | SAR 448.38 | 3.92% down | 230% up | ||
| 42 | HaemoneticsHAE · Health Care | 7.90% | SAR 20.5B | SAR 450.78 | 0.17% down | 53% up | ||
| 43 | InsuletPODD · Health Care | 7.68% | SAR 34.7B | SAR 499.59 | 2.96% down | 59% down | ||
| 44 | GlaukosGKOS · Health Care | 7.57% | SAR 52.7B | SAR 890.27 | 0.33% down | 139% up | ||
| 45 | ResMedRMD · Health Care | 7.44% | SAR 124.3B | SAR 883.97 | 0.53% down | 6% down | ||
| 46 | BrukerBRKR · Health Care | 7.37% | SAR 32.3B | SAR 211.81 | 9.08% down | 31% up | ||
| 47 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SAR 43.9B | SAR 226.63 | 1.64% down | 12% up | ||
| 48 | Globus MedicalGMED · Health Care | 7.14% | SAR 33.2B | SAR 250.94 | 2.49% down | 20% down | ||
| 49 | Adaptive BiotechnologiesADPT · Health Care | 7.09% | SAR 17B | SAR 104.78 | 0.43% down | 51% up | ||
| 50 | Definium TherapeuticsDFTX · Health Care | 7.02% | SAR 14.6B | SAR 106.32 | 3.87% down | 176% up | ||
| 51 | Guardant HealthGH · Health Care | 6.97% | SAR 74B | SAR 547.08 | 0.16% up | 38% up | ||
| 52 | Merit Medical SystemsMMSI · Health Care | 6.67% | SAR 19B | SAR 316.40 | 0.08% down | 3% down | ||
| 53 | HealthEquityHQY · Health Care | 6.62% | SAR 29.4B | SAR 355.45 | 2.70% down | 4% down | ||
| 54 | Elanco Animal HealthELAN · Health Care | 6.59% | SAR 48.3B | SAR 96.56 | 2.09% down | 18% up | ||
| 55 | HeartflowHTFL · Health Care | 6.47% | SAR 15.4B | SAR 175.16 | 4.62% up | 45% up | ||
| 56 | InsmedINSM · Health Care | 6.42% | SAR 116.3B | SAR 530.20 | 2.17% down | 27% down | ||
| 57 | Charles River Laboratories InternationalCRL · Health Care | 6.23% | SAR 56.5B | SAR 1,179.17 | 4.15% down | 96% up | ||
| 58 | BillionToOneBLLN · Health Care | 6.22% | SAR 16.1B | SAR 337.33 | 0.31% down | 18% down | ||
| 59 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SAR 25.5B | SAR 485.29 | 4.66% down | 9% down | ||
| 60 | ChemedCHE · Health Care | 6.14% | SAR 26.7B | SAR 2,058.04 | 0.50% down | 25% up | ||
| 61 | Legend BiotechLEGN · Health Care | 6.13% | SAR 11.1B | SAR 57.21 | 5.28% down | 43% down | ||
| 62 | PenumbraPEN · Health Care | 6.10% | SAR 47.2B | SAR 1,197.18 | 0.28% down | 11% up | ||
| 63 | Revolution MedicinesRVMD · Health Care | 6.05% | SAR 130.8B | SAR 604.74 | 1.11% up | 125% up | ||
| 64 | RevvityRVTY · Health Care | 5.85% | SAR 60.8B | SAR 544.79 | 4.20% down | 54% up | ||
| 65 | BrightSpring Health ServicesBTSG · Health Care | 5.83% | SAR 46.9B | SAR 235.93 | 1.77% down | 85% up | ||
| 66 | Align TechnologyALGN · Health Care | 5.83% | SAR 41B | SAR 582.12 | 2.82% down | 12% up | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.83% | SAR 57.2B | SAR 564.86 | 3.84% down | 10% up | ||
| 68 | Molina HealthcareMOH · Health Care | 5.59% | SAR 38.9B | SAR 744.26 | 2.43% down | 44% up | ||
| 69 | Lantheus HoldingsLNTH · Health Care | 5.57% | SAR 25.1B | SAR 383.03 | 0.00% | 83% up | ||
| 70 | Oscar HealthOSCR · Health Care | 5.39% | SAR 28.8B | SAR 92.77 | 5.50% down | 94% up | ||
| 71 | Cooper CompaniesCOO · Health Care | 5.32% | SAR 42B | SAR 220.89 | 2.40% down | 20% down | ||
| 72 | IlluminaILMN · Health Care | 5.31% | SAR 109.4B | SAR 723.36 | 3.90% down | 62% up | ||
| 73 | Summit TherapeuticsSMMT · Health Care | 5.28% | SAR 29.9B | SAR 37.33 | 5.87% down | 35% down | ||
| 74 | IncyteINCY · Health Care | 5.22% | SAR 87.7B | SAR 430.02 | 1.07% down | 14% up | ||
| 75 | Medpace HoldingsMEDP · Health Care | 4.95% | SAR 64.1B | SAR 2,290.44 | 3.70% down | 7% up | ||
| 76 | Bio-TechneTECH · Health Care | 4.90% | SAR 42.8B | SAR 272.62 | 0.04% down | 18% up | ||
| 77 | Baxter InternationalBAX · Health Care | 4.58% | SAR 49.3B | SAR 95.25 | 0.00% | 39% up | ||
| 78 | Universal Health ServicesUHS · Health Care | 4.42% | SAR 38.8B | SAR 673.13 | 2.54% up | 25% down | ||
| 79 | United TherapeuticsUTHR · Health Care | 4.31% | SAR 88.6B | SAR 2,081.07 | 0.78% down | 18% up | ||
| 80 | Bio-Rad LaboratoriesBIO · Health Care | 4.30% | SAR 36.2B | SAR 1,346.41 | 2.34% down | 16% up | ||
| 81 | DexComDXCM · Health Care | 4.27% | SAR 111B | SAR 297.57 | 1.08% down | 33% up | ||
| 82 | NateraNTRA · Health Care | 4.19% | SAR 148.7B | SAR 1,025.66 | 5.70% down | 26% up | ||
| 83 | Zimmer Biomet HoldingsZBH · Health Care | 4.15% | SAR 71.8B | SAR 379.28 | 0.36% down | 10% up | ||
| 84 | ZoetisZTS · Health Care | 4.12% | SAR 120.6B | SAR 296.78 | 2.08% down | 34% down | ||
| 85 | Option Care HealthOPCH · Health Care | 4.10% | SAR 17.8B | SAR 118.51 | 0.06% down | 7% up | ||
| 86 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SAR 72.3B | SAR 539.54 | 2.71% down | 66% down | ||
| 87 | GE HealthCare TechnologiesGEHC · Health Care | 4.04% | SAR 136.8B | SAR 302.52 | 1.53% down | 7% up | ||
| 88 | Caris Life SciencesCAI · Health Care | 4.01% | SAR 18.9B | SAR 65.95 | 5.18% down | 23% down | ||
| 89 | AvantorAVTR · Health Care | 3.97% | SAR 37.7B | SAR 55.67 | 1.85% down | 31% up | ||
| 90 | BiogenBIIB · Health Care | 3.69% | SAR 138.4B | SAR 936.34 | 1.00% up | 41% up | ||
| 91 | Encompass HealthEHC · Health Care | 3.68% | SAR 49.2B | SAR 501.39 | 1.04% up | 16% up | ||
| 92 | LifeStance Health GroupLFST · Health Care | 3.59% | SAR 19.7B | SAR 51.85 | 3.60% up | 107% up | ||
| 93 | MiniMed GroupMMED · Health Care | 3.49% | SAR 16.9B | SAR 60.06 | 1.54% down | 12% down | ||
| 94 | Belite BioBLTE · Health Care | 3.40% | SAR 19.4B | SAR 477.87 | 15.65% down | 25% up | ||
| 95 | Quest DiagnosticsDGX · Health Care | 3.39% | SAR 106.6B | SAR 968.94 | 0.31% down | 35% up | ||
| 96 | Cardinal HealthCAH · Health Care | 3.28% | SAR 236.6B | SAR 1,023.45 | 0.17% up | 30% up | ||
| 97 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SAR 27.6B | SAR 79.23 | 1.26% down | 79% up | ||
| 98 | Labcorp HoldingsLH · Health Care | 3.13% | SAR 111.8B | SAR 1,377.29 | 0.47% down | 39% up | ||
| 99 | Mettler-Toledo InternationalMTD · Health Care | 3.10% | SAR 124.4B | SAR 6,253.30 | 2.27% down | 17% up | ||
| 100 | ViatrisVTRS · Health Care | 3.07% | SAR 84.4B | SAR 73.64 | 1.26% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7515 SAR).
Questions and answers
Which health care companies in the United States rank first by short interest?
Hims & Hers Health (22.0%), Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%) are the top three of the 140 health care companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care companies in the United States are in this ranking?
140 are ranked by short interest.
What are these health care companies in the United States worth together?
The 140 health care companies in the United States ranked by short interest have a combined market value of SAR 27.39T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care companies in the United States by short interest”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.